Wang, Qian <br/><br/>
A Minimal lncRNA-mRNA Signature Predicts Sensitivity to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.  [electronic resource] 

 -  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology  2018 
 - 2539-2548 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1421-9778 
<br/><br/><label>Standard No.: </label>10.1159/000492698  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols<br/>Area Under Curve<br/>Cyclophosphamide--administration & dosage<br/>Databases, Genetic<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Paclitaxel--administration & dosage<br/>RNA, Long Noncoding--genetics<br/>RNA, Messenger--metabolism<br/>ROC Curve<br/>Remission Induction<br/>Transcriptome<br/>Triple Negative Breast Neoplasms--drug therapy